>

Dr Reddys Story

<div class='circular--portrait' style='background:#754DEB;color: white;font-size:4em;padding-top: 25px;;'>DR</div>
RDY -- USA Stock  

USD 45.26  0.19  0.42%

RDY headline and social signals for Dr Reddys on the 30th of December with financial sentiment analysis on the company that can be used to derive useful patterns or a particular trading strategy for Dr Reddys. Additionally take a look at Dr Reddys Hype Analysis, Dr Reddys Correlation and Dr Reddys Performance.
Dr. Reddys Launches Generic Equivalent Of Nitropress Injection - Nasdaq
Dr. Reddys Launches Generic Equivalent Of Nitropress Injection NasdaqDr. Reddys Laboratories Announces the Launch of Sodium Nitroprusside Injection, 50 mg2 mL Single-dose Vial in the US Market StreetInsider.comDr. Reddys Laboratories launches Sodium Nitroprusside Injection, 50 mg2 ml Single-dose Vial in the U.S. Market Equity BullsDr Reddys inches up on launching Sodium Nitroprusside Injection in US IndiainfolineView full coverage on Google News

Read More...   

Story Momentum

This article from www.nasdaq.com published on the 30th of December contributed to the next trading period price depreciation.The trading delta at closing time to the next next day price was 0.42% . The overall trading delta when the story was published to current price is 1.25% .

Similar stores for Dr Reddys

3 days ago at www.equitybulls.com 
Dr. Reddys Laboratories Ltd successfully completes USFDA audit at Formulations Srikakulam Plant - Equity Bulls
news
Dr. Reddys Laboratories Ltd successfully completes USFDA audit at Formulations Srikakulam Plant Equity Bulls
over two weeks ago at www.smarteranalyst.com 
Dr Reddys Laboratories Gets a Hold Rating from Barclays - Smarter Analyst
news
Dr Reddys Laboratories Gets a Hold Rating from Barclays Smarter Analyst
over a month ago at rivertonroll.com 
Hexavest Inc. Reduces Position in Dr.Reddys Laboratories Ltd - Riverton Roll
news
Hexavest Inc. Reduces Position in Dr.Reddys Laboratories Ltd Riverton Roll
over a month ago at economictimes.indiatimes.com 
Buy Dr. Reddys Labs, price target Rs 2980 Kunal Bothra - Economic Times
news
Buy Dr. Reddys Labs, price target Rs 2980 Kunal Bothra Economic Times

Number of Shares Shorted

Number of Shares Shorted Comparative Analysis

  Number of Shares Shorted 
    
  Dr Reddys Comparables 
Dr Reddys is rated second in number of shares shorted category among related companies. Number of Shares Shorted is total amount of shares that are currently sold short by investors. When stock is sold short, the short seller assumes the responsibility of buying the stock back at a lower price. The speculator will make money if the stock goes down in price or will experience loss if the stock price goes up.
Additionally take a look at Dr Reddys Hype Analysis, Dr Reddys Correlation and Dr Reddys Performance. Please also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Company logos by clearbit